Literature DB >> 15262699

Poor prognosis of arthritis-associated pyoderma gangrenosum.

Carlos A Charles1, Tracy L Bialy, Anna F Falabella, William H Eaglstein, Francisco A Kerdel, Robert S Kirsner.   

Abstract

BACKGROUND: The association between pyoderma gangrenosum (PG) and arthritis is well established. We have observed a refractory population of patients with arthritis-associated PG (PGA). We, therefore, tested the hypothesis that differences exist in response to treatment in patients with PGA compared with patients with PG without arthritis. OBSERVATIONS: We performed a review of patients with PG during a 2-year period. Patients had noninfectious chronic ulcerations clinically typical for PG, exclusion of relevant differential diagnoses, and consistent histopathological features. Outcomes compared between patients with arthritis (PGA) and without arthritis (PG) included complete healing, percentage change in wound size, and duration of therapy. Of 10 PG ulcers, 7 healed, compared with 2 of 8 PGA ulcers. There was a greater mean percentage decrease in wound size in the PG vs the PGA ulcers (78.9% vs 23.4%; P =.10) and a shorter mean duration of treatment (8.7 vs 14.8 months; P =.18).
CONCLUSIONS: The ulcers of patients with PGA seem more refractory to treatment than the ulcers of patients with PG alone. Those with PGA ulcers represent a refractory subset of patients, and the ulcers are possibly secondary to unique pathophysiological features.

Entities:  

Mesh:

Year:  2004        PMID: 15262699     DOI: 10.1001/archderm.140.7.861

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Extra-articular Manifestations in Rheumatoid Arthritis.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie; R Tanasescu
Journal:  Maedica (Buchar)       Date:  2010-12

Review 2.  Management of pyoderma gangrenosum.

Authors:  Alexandra Teagle; Rachel Hargest
Journal:  J R Soc Med       Date:  2014-06-09       Impact factor: 5.344

3.  Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.

Authors:  Erika Sawka; Allison Zhou; Emile Latour; Marcia Friedman; Alex G Ortega-Loayza
Journal:  Clin Rheumatol       Date:  2021-05-18       Impact factor: 3.650

Review 4.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

5.  Pyoderma Gangrenosum Associated With Seronegative Arthritis: A Rural Tertiary Care Experience.

Authors:  Tanishq S Sharma; Dr Roy Mali; Hardil P Majmudar; Saptak P Mankad
Journal:  Cureus       Date:  2021-04-30

6.  Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.

Authors:  Elizabeth A Wang; Andrea Steel; Guillaume Luxardi; Anupam Mitra; Forum Patel; Michelle Y Cheng; Reason Wilken; Jason Kao; Kristopher de Ga; Hawa Sultani; Alexander A Merleev; Alina I Marusina; Alain Brassard; Maxwell A Fung; Thomas Konia; Michiko Shimoda; Emanual Maverakis
Journal:  Front Immunol       Date:  2018-01-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.